IMRX:NASDAQImmuneering Corporation analysis

The moving-average structure behind Immuneering Corporation is neutral at $4.33, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 4.8%. Relative strength is 35.7 — approaching oversold — and the MACD signal is bearish. Watch $4.24 as support and $5.43 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 296.5% above today's level.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 51.2%, a beta of 1.20 and a maximum drawdown of 57.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.